DeepTek CXR Analyzer

by DeepTek Medical Imaging Pvt  · Based in India →FDA-Cleared AI for Medical Imaging: Chest X-ray AI Solution for Workflow Automation
Cardiology Pulmonology Radiology

Contact sales
Regulatory Status Disclosed

Overview

DeepTek CXR Analyzer is a revolutionary, US FDA-cleared computer-assisted detection (CADe) software device designed to assist radiologists in interpreting adult frontal chest radiographs. Leveraging advanced deep learning algorithms, the tool automatically identifies, categorizes, and highlights suspicious regions of interest (ROIs) across a broad range of lung, pleural, and cardiac pathologies, as well as foreign bodies or hardware on the chest.

This innovative AI solution aims to significantly reduce radiologist workload by an impressive 30-50% and boost productivity by 2x to 3x, streamlining the diagnostic workflow. It integrates seamlessly with existing Picture Archiving and Communication Systems (PACS) using DICOM format, operating either on-premise or in the cloud without disrupting current workflows. The CXR Analyzer is compatible with various X-ray machines, including hospital-based, mobile, portable, handheld, and ultra-portable units, making it a versatile and powerful tool for diverse healthcare settings.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays
  • Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware
  • Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs)
  • Seamless DICOM-based PACS integration (on-premise or cloud)
  • Intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive'
  • Reduces radiologist workload by 30-50% and boosts productivity by 2x-3x
  • Generates secondary capture DICOM with AI output for easy interpretation
  • Compatible with various X-ray modalities (hospital, mobile, portable, handheld)
  • Smart reporting features and worklist prioritization
  • WHO-recommended for TB screening (DeepTek's CXR AI solution)

Use Cases

  • Assisting radiologists in interpreting chest X-rays
  • Automating radiology workflow and triaging cases
  • Early detection and diagnosis of lung infections, cancer, and chronic lung diseases
  • Large-scale tuberculosis (TB) screening programs
  • Reducing diagnostic turnaround time and improving reporting efficiency
  • Enhancing diagnostic accuracy in routine lung screenings and public health initiatives

What Physicians Need to Know

Heart Failure Risk Prediction
DeepTek CXR Analyzer assists in identifying suspicious regions of interest in the cardiac area and provides automatic calculation of the cardiothoracic ratio (CTR), which is a key indicator for cardiomegaly. Cardiomegaly can suggest conditions like hypertension, coronary artery disease, cardiomyopathies, and valvular heart disease, aiding in the early diagnosis of clinical conditions associated with heart failure.
Cardiac Monitoring Integration
The CXR Analyzer integrates seamlessly with existing Picture Archiving and Communication Systems (PACS), operating in the background (on-premise or cloud) without altering current workflows. It transmits DICOM images for AI analysis and sends outputs back to PACS as secondary captures, highlighting findings with colored bounding boxes. The associated Augmento platform also features an inbuilt notification system to alert physicians, administrators, and patients.
AHA/ACC Guideline Alignment
DeepTek CXR Analyzer is a US FDA-cleared Computer-Assisted Detection (CADe) solution. It also holds CE Mark, HSA Approval, CDSCO Approved, Malaysia Board Approval, MoH Indonesia Approved, and Thai FDA Approved, indicating adherence to various international regulatory and quality standards.
Real-Time Alert Capability
The AI-powered analysis triages scans in the backend, categorizing outputs into AI-negative or AI-positive findings. This intelligent segregation and the automated output to PACS with highlighted regions of interest enable quick identification of critical cases. The platform's smart notification system further supports timely alerts to healthcare professionals and patients.
Physician Tip

DeepTek CXR Analyzer serves as a valuable concurrent reading aid for radiologists, enhancing the detection of suspicious cardiac regions and cardiomegaly from chest X-rays. Leverage its seamless PACS integration and AI-driven triaging to prioritize urgent cases and improve reporting efficiency. While the tool provides critical insights from CXRs, remember it is a CADe solution and should be used in conjunction with comprehensive clinical evaluation and other diagnostic modalities for a complete cardiac assessment. Pay close attention to the highlighted bounding boxes for suspicious findings in the cardiac region, as these can be early indicators of underlying cardiovascular conditions.

The DeepTek CXR Analyzer is designed for effortless integration with existing PACS systems, supporting both on-premise and cloud deployments. It functions in the background, receiving DICOM images and returning AI-analyzed results as secondary captures directly into the PACS workflow. This ensures minimal disruption to current radiology workflows. The platform also offers integration with the Augmento cloud-based PACS and AI deployment platform, which includes smart reporting and notification functionalities.

Details

Category Cardiology AI, Radiology & Imaging AI
Pricing Contact sales Pay-per-use; available as a technology offering or an AI-assisted reporting service.
DeploymentCloud; On-premise
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

DeepTek CXR Analyzer v1.0 received US FDA 510(k) clearance (K231001) on October 5, 2023, as a Class II computer-assisted detection (CADe) software device. It is intended to assist radiologists in identifying suspicious regions of interest (ROIs) in lungs, pleura, cardiac, and hardware in adult frontal chest radiographs.

Integrations
EHR Not specified
Specialties Cardiology, Pulmonology, Radiology

What the Web Says

DeepTek CXR Analyzer is an AI-powered computer-assisted detection (CADe) solution designed to help radiologists interpret chest X-rays. It identifies, categorizes, and highlights suspicious regions of interest across a broad range of lung, pleural, cardiac pathologies, and hardware. The solution has received US FDA clearance and CE certification under EU MDR, and has been recommended by the WHO for TB screening.

Overall: Positive

Strengths

  • Reduces radiologist workload by an impressive 30-50%.
  • Accelerates decision-making by detecting and locating suspicious lesions.
  • Covers the entire chest area, offering analysis for a broad range of pathologies, not just specific ones.
  • Compatible with various X-ray machines, including hospital-based, mobile, portable, hand-held, and ultra-portable units, making it versatile.
  • Seamless integration with existing PACS without altering current workflows.
  • Can interpret pediatric chest X-rays for children aged four and above, including detection of pediatric tuberculosis and pneumonia.

Limitations

  • Intended as an adjunct tool and does not replace the role of radiologists; output should not be used as the primary interpretation.
  • Not designed to detect conditions other than those classified under Lung, Cardiac, Pleura, and Hardware.
  • Some AI solutions for TB detection have shown significantly lower performance among participants with a past history of TB.
  • Performance can be affected by the radiography equipment used to capture the CXR image.
  • One Reddit comment suggests that some AI software can be more of a hindrance than a help, though this is a general comment about AI in radiology and not specific to DeepTek CXR Analyzer.

Based on reviews from: DeepTek, FDA.report, Healthcare Radius, AuntMinnie, Reddit, Vertex AI Search

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate DeepTek CXR Analyzer

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

DeepTek.ai
DeepTek.ai secures US FDA clearance for its ground-breaking Chest X-ray AI solution
DeepTek.ai announced it received US FDA clearance for its CXR Analyzer, an AI solution that uses deep learning to detect, categorize, and highlight anomalies in chest X-rays, aiming to reduce radiologist workload by 30-50%.
2023-10
Imaging Technology News
DeepTek.ai secures US FDA clearance for its groundbreaking Chest X-ray AI solution | Imaging Technology News
DeepTek.ai's CXR Analyzer, an AI solution for chest X-rays, received US FDA clearance. This technology uses deep learning to identify and highlight suspicious areas across the entire chest, including lung, pleural, and cardiac pathologies, and is compatible with various X-ray machines.
2023-10
AuntMinnie
Blackford adds DeepTek CXR analyzer - AuntMinnie
Blackford and DeepTek are partnering to integrate the AI-driven CXR Analyzer into the Blackford Platform. This FDA-cleared CADe software analyzes the entire lung, pleura, and cardiac regions to identify suspicious areas and integrates seamlessly with existing PACS.
2024-11
mobile.Medimaging.net
Groundbreaking AI Solution Automatically Detects Abnormalities in Chest X-Rays - Radiography - mobile.Medimaging.net
DeepTek Medical Imaging's CXR Analyzer, an AI solution, has received US FDA clearance for detecting abnormalities in chest X-rays. It uses deep learning to identify, categorize, and highlight suspicious areas, covering the entire chest for various pathologies and compatible with diverse X-ray devices.
2023-10
Express Healthcare
DeepTek receives USFDA clearance for its chest X-ray AI solution - Express Healthcare
DeepTek.ai has secured US FDA clearance for its CXR Analyzer, an AI solution that employs deep learning algorithms to detect and highlight abnormalities in chest X-rays. This technology aims to reduce radiologist workload by 30-50% and is compatible with various X-ray machines.
2023-10
Express Healthcare
DeepTek's Chest X-ray AI solution receives CE MDR Class IIb certification
DeepTek's Chest X-ray AI solution has received CE certification under the European Union Medical Device Regulation (EU MDR) as a Class IIb medical device. This certification allows for expanded deployment across Europe and other regions, particularly benefiting areas with high TB burden and limited radiology access.
2025-04
FDA
Establishment Registration & Device Listing - FDA
The FDA lists DeepTek CXR Analyzer (Product Code: MYN) as a Class 2 medical image analyzer, with its premarket submission number K231001.
2026-06
unknown
Applications of AI/ML in accelerating the development of pulmonary drug delivery system
DeepTek CXR Analyzer v1.0 is mentioned in a review article discussing applications of AI and machine learning in respiratory disease detection, specifically for identifying suspicious lesions in the chest region from CXR images.
unknown

Videos

Product demos, reviews, and walkthroughs for DeepTek CXR Analyzer.

View all on YouTube

Frequently Asked Questions

DeepTek CXR Analyzer integrates seamlessly with existing PACS systems, operating in the background to analyze chest X-ray DICOM images. It uses deep learning to identify, categorize, and highlight suspicious regions of interest across lung, pleural, cardiac pathologies, and foreign bodies/hardware, acting as a concurrent reading aid for radiologists. This can accelerate decision-making and potentially reduce radiologist workload by 30-50%.
DeepTek CXR Analyzer has received US FDA 510(k) clearance, CE Mark as a Class IIb medical device, and approvals from several other international health authorities including Singapore HSA and Malaysia MDA. It also adheres to global security and privacy standards, being HIPAA and GDPR compliant, and ISO 27001 certified.
The CXR Analyzer is intended as a concurrent reading aid and does not replace a radiologist's primary interpretation; physicians must review original images for all suspected ROIs. It is primarily indicated for adults and transitional adolescents, though newer versions also support pediatric chest X-rays for certain conditions, and its performance can vary with different radiography systems. It is not designed to detect conditions other than those classified under Lung, Cardiac, Pleura, and Hardware.
Several other AI solutions offer chest X-ray analysis, including Lunit INSIGHT CXR, Annalise.ai Enterprise CXR, and Rayscape CXR. These alternatives often provide similar functionalities like pathology detection, triage, and workflow enhancement, though their specific features and regulatory clearances may vary. Other solutions like Aidoc and AZmed Rayvolve also operate in the medical imaging AI space.
Specific pricing details for DeepTek CXR Analyzer are not publicly disclosed, as is common for enterprise-level healthcare AI solutions. Pricing models typically involve subscriptions or licensing agreements tailored to the size and specific needs of the healthcare institution. Interested parties usually need to contact DeepTek directly for a customized quote and further information.
The standalone AI has demonstrated an aggregate AUROC of 91.2% and a sensitivity of 88.4% for detecting suspicious ROIs in lung, pleural, and cardiac regions across different hospital datasets. Studies indicate that AI assistance can significantly improve radiologists' average sensitivity and AUROC, with the analyzer outperforming unaided human readers in detecting suspicious ROIs.

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.